The insider selling is routine and tied to recent stock grants, no bearish signal. Monitor the next quarterly earnings (likely late October) for fundamental updates; the 95% analyst bullish consensus and $4.1B market cap suggest the stock is well-covered and the selling is not a red flag.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 12 $125.35entry
- T+1 · 3mo ago −1.75%α −2.44% · $123.16
- T+5 · 3mo ago −0.48%α −0.03% · $124.75
- T+20 · 2mo ago −9.95%α −8.05% · $112.88
- T+60 · 12d ago +3.86%α +8.97% · $130.19
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Multiple C-suite and EVP insiders at iRhythm sold a total of ~$1.55M in stock over a one-week window, including the Chief Medical Officer, Chief Communications & Product Officer, and Chief Risk Officer. The selling follows a cluster of non-cash stock grants on August 7, suggesting the sales are primarily liquidity-driven to cover tax obligations or diversify concentrated positions, rather than a bearish signal on fundamentals. The total value represents ~0.04% of the $4.1B market cap, well below the 0.1% materiality threshold, making this a routine insider transaction cluster with no actionable trading signal.
Key Financial Metrics
Key Facts
- Three C-suite officers (Chief Medical/Science Officer, Chief Communications & Product Officer, Chief Risk Officer) sold shares totaling ~$2.44M in the cluster window.
- The largest sale was by Minang Turakhia (Chief Medical/Science Officer) for ~$884K on August 10.
- All three selling officers received non-cash stock grants on August 7 (13,589, 9,706, and 13,589 shares respectively), indicating the sales are likely for tax withholding or diversification.
- Total open-market sales of ~$1.55M represent ~0.04% of iRhythm's $4.1B market cap, well below the 0.1% materiality threshold for insider clusters.
- The cluster includes a fourth insider (EVP Strategic Business Ops, EVP Chief People Officer) selling smaller amounts on August 3.
Financial Impact
Total insider open-market sales of ~$1.55M, representing ~0.04% of market cap, immaterial relative to company size.
Risk Factors
- Insider selling could be misinterpreted by the market as a negative signal despite being liquidity-driven.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-IRTC-1786478500772 |
Track record
31 reports on IRTC
8 of 11 bullish or bearish reports moved the stock their way by T+5. Best: +16.85% at T+60 after the Feb 25, 2026 report. 10 of 11 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $90.12 Now $90.83 +0.79% settles Nov 23
- Nov 13, 20263d ago 8-K Neutral 2/10 Entry $91.91 Now $90.83 −1.18% settles Nov 20
- Nov 12, 20264d ago SC 13G/A Neutral 3/10 Entry $93.56 Now $90.83 −2.92% settles Nov 19
- Nov 12, 20264d ago 8-K Neutral 4/10 Entry $93.56 Now $90.83 −2.92% settles Nov 19
- Nov 11, 20265d ago Press Release Neutral 3/10 Entry $93.56 Now $90.83 −2.92% settles Nov 19
- Nov 5, 202611d ago 8-K Mixed 6/10 No price data
- Nov 5, 202611d ago Press Release Bullish 6/10 Entry $90.22 to $91.91 Now $90.83 +0.68% ▲ +1.87% −0.72% vs SPY
- Oct 27, 202620d ago Institutional Cluster Mixed 4/10 Entry $123.99 to $134.00 Now $90.83 −26.74% ▲ +8.07% +8.79% vs SPY
- Oct 15, 20264w ago Press Release Neutral 1/10 Entry $108.66 Now $90.83 −16.41% No price data
- Oct 13, 20264w ago SC 13G/A Neutral 2/10 Entry $106.05 to $113.55 Now $90.83 −14.35% ▲ +7.07% +6.62% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers